Literature DB >> 11830542

MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer.

Françoise Charbonnier1, Sylviane Olschwang, Qing Wang, Cécile Boisson, Cosette Martin, Marie-Pierre Buisine, Alain Puisieux, Thierry Frebourg.   

Abstract

To estimate the relative frequency of mismatch repair genes, rearrangements in hereditary nonpolyposis colorectal cancer (HNPCC) families without detectable mutations in MSH2 or MLH1, we have analyzed by multiplex PCR of short fluorescent fragments MSH2, MLH1, and MSH6 in 61 families, either fulfilling Amsterdam criteria or including cases of multiple primary cancers belonging to the HNPCC spectrum. We detected 13 different genomic rearrangements of MSH2 in 14 families (23%), whereas we found no rearrangement of MLH1 and MSH6. Analysis of 31 other families, partially meeting Amsterdam criteria, revealed no additional rearrangement of MSH2. All of the MSH2 rearrangements, except one, corresponded to genomic deletions involving one or several exons. In 8 of 13 families with a MSH2 genomic deletion, the MSH2 promoter was also deleted, and the 5' breakpoint was located either within or upstream the MSH2 gene. This study demonstrates the heterogeneity of MSH2 exonic and promoter rearrangements and shows that, in HNPCC families without detectable MSH2 or MLH1 point mutation, one must consider the presence of MSH2 genomic rearrangements before the involvement of other mismatch repair genes. The simplicity and rapidity of their detection, using fluorescent multiplex PCR, led us to recommend to begin the molecular analysis in HNPCC by screening for MSH2 rearrangements.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11830542

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

1.  NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes.

Authors:  Jenny Douglas; Sandra Hanks; I Karen Temple; Sally Davies; Alexandra Murray; Meena Upadhyaya; Susan Tomkins; Helen E Hughes; Trevor R P Cole; Nazneen Rahman
Journal:  Am J Hum Genet       Date:  2002-12-02       Impact factor: 11.025

2.  Early onset brain tumor and lymphoma in MSH2-deficient children.

Authors:  Gaëlle Bougeard; Françoise Charbonnier; Alexandre Moerman; Cosette Martin; Marie M Ruchoux; Nathalie Drouot; Thierry Frébourg
Journal:  Am J Hum Genet       Date:  2003-01       Impact factor: 11.025

Review 3.  Lower gastrointestinal tract cancer predisposition syndromes.

Authors:  Neel B Shah; Noralane M Lindor
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

4.  Molecular evaluation of foetuses with holoprosencephaly shows high incidence of microdeletions in the HPE genes.

Authors:  Claude Bendavid; Christèle Dubourg; Isabelle Gicquel; Laurent Pasquier; Pascale Saugier-Veber; Marie-Renée Durou; Sylvie Jaillard; Thierry Frébourg; Bassem R Haddad; Catherine Henry; Sylvie Odent; Véronique David
Journal:  Hum Genet       Date:  2005-12-02       Impact factor: 4.132

5.  A comprehensive profile of DNA copy number variations in a Korean population: identification of copy number invariant regions among Koreans.

Authors:  Jae Pil Jeon; Sung Mi Shim; Jong Sun Jung; Hye Young Nam; Hye Jin Lee; Berm Seok Oh; Kuchan Kim; Hyung Lae Kim; Bok Ghee Han
Journal:  Exp Mol Med       Date:  2009-09-30       Impact factor: 8.718

6.  Novel and recurrent rearrangements in the CFTR gene: clinical and laboratory implications for cystic fibrosis screening.

Authors:  Feras M Hantash; Joy B Redman; Kelsey Starn; Ben Anderson; Arlene Buller; Matthew J McGinniss; Franklin Quan; Mei Peng; Weimin Sun; Charles M Strom
Journal:  Hum Genet       Date:  2005-12-17       Impact factor: 4.132

7.  The three nucleotide deletion within the 3'untranslated region of MLH1 resulting in gene expression reduction is not a causal alteration in Lynch syndrome.

Authors:  J Tinat; S Baert-Desurmont; J B Latouche; S Vasseur; C Martin; E Bouvignies; T Frébourg
Journal:  Fam Cancer       Date:  2008-05-22       Impact factor: 2.375

8.  Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.

Authors:  Paul J Goodfellow; Barbara M Buttin; Thomas J Herzog; Janet S Rader; Randall K Gibb; Elizabeth Swisher; Katherine Look; Ken C Walls; Ming-Yu Fan; David G Mutch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

9.  Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.

Authors:  Katarina Zavodna; Tomas Krivulcik; Maria Gerykova Bujalkova; Tomas Slamka; David Martinicky; Denisa Ilencikova; Zdena Bartosova
Journal:  BMC Cancer       Date:  2009-11-20       Impact factor: 4.430

10.  Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification.

Authors:  D J Bunyan; D M Eccles; J Sillibourne; E Wilkins; N Simon Thomas; J Shea-Simonds; P J Duncan; C E Curtis; D O Robinson; J F Harvey; N C P Cross
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.